Australia: Meeting regulatory requirements through the use of GS1 standards
The regulatory requirements related to pharmaceuticals are focused on the detection of falsified medicines and the traceability of prescription medicines.
Body
Pharmaceutical firm Aspen has implemented a GS1 standards-based serialisation system, enabling full regulatory compliance across multiple nations.
Several countries now require serial numbers to be present on pharmaceutical products, and forthis data to be transferred from the manufacturer to the regulator. In 2017, the pharmaceutical company Aspen Australia was awarded a significant contract manufacturing portfolio, with many of the resulting products being exported to nations in which such requirements were in place. The firm therefore needed to implement a solution to ensure compliance.
File
